169327 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
BIOMARKER-BASED TREATMENT AND DIAGNOSTIC METHODS FOR IL-17-DEPENDENT CONDITIONS
#2DIAGNOSTIC METHOD OF A SKIN SHOWING SIGNS OF AGING
#3BIOMARKER-BASED TREATMENT AND DIAGNOSTIC METHODS FOR IL-17-DEPENDENT CONDITIONS
#4SKIN BIOMARKER
#5ANTI-TUMOUR RESPONSES TO CYTOKERATINS
#6BIOMARKER-BASED TREATMENT AND DIAGNOSTIC METHODS FOR IL-17-DEPENDENT CONDITIONS
#7COMPOSITION FOR PREVENTION OR TREATMENT OF ATOPIC DERMATITIS COMPRISING AKT SIGNALING PATHWAY INHIBITOR AS ACTIVE INGREDIENT
#8Methods of Predicting Atopic Dermatitis
#9PREVENTION AND/OR TREATMENT OF INFLAMMATORY SKIN DISEASE
#10DIFFERENTIAL DIAGNOSIS OF ECZEMA AND PSORIASIS
#11Generating skincare product recommendations for a user based on skincare product attributes and user location and demographic data
#12METHODS FOR DETERMINING THE MOISTURE CONTENT OF THE SKIN
#13Apparatus and method for estimating body water status
#14Biomarkers Predictive of Atopic Dermatitis
#15BIOMARKERS AND CLASSIFIER OF PSORIASIS AND METHODS OF TREATMENT
#16SYSTEMS AND METHODS FOR GENERATING PERSONALIZED SKINCARE FORMULATIONS BASED ON BIOMARKER ANALYSIS
#17Composition for preventing or treating keloids or hypertrophic scars
#18METHOD FOR DIAGNOSING ESTHETIC DEGRADATIONS OF SKIN
#19MELANOGENESIS DETECTION METHOD USING FAM86A
#20MONOCLONAL ANTIBODIES AGAINST LORICRIN
#21COMPOSITION FOR PREVENTING OR TREATING KELOIDS OR HYPERTROPHIC SCARS
#22Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#23Epidermal microfluidic sensor for sweat collection and analysis from aquatic athletes
#24Methods and Systems for Improving Skin Condition
#25NEW BIOMARKERS OF HUMAN SKIN AGING
#26Personalized skincare recommendations based on biomarker analysis
#27Systems and methods for generating personalized skincare formulations based on biomarker analysis
#28DIAGNOSTIC FOR SJORGREN'S SYNDROME BASED ON A BIOMARKER
#29Elastin Assay
#30DIAGNOSTIC METHOD OF A SKIN SHOWING SIGNS OF AGING
#31GENE CLASSIFIERS FOR USE IN MONITORING UV DAMAGE
#32Epidermal microfluidic sensor for sweat collection and analysis from aquatic athletes
#33METHOD OF DIAGNOSIS OF THE AESTHETIC QUALITIES OF THE SKIN
#34Prevention and/or treatment of inflammatory skin disease
#35Composition for skin aging measurement, prevention, or alleviation, using HAPLN1
#36MASS SPECTROMETRY IMAGING OF BENIGN MELANOCYTIC NEVI AND MALIGNANT MELANOMAS
#37Protein Biomarkers for Identifying and Treating Aging Skin and Skin Conditions
#38METHOD FOR DIAGNOSING A SKIN DISPLAYING SIGNS OF DRYNESS
#39Compositions and methods for enhancing neuro-repair
#40Differential diagnosis of eczema and psoriasis
#41TRPA1 and TRPV4 inhibitors and methods of using the same for organ-specific inflammation and itch
#42BIOLOGICAL SAMPLE COLLECTION METHOD AND BIOLOGICAL SAMPLE COLLECTION TOOL
#43Method for evaluating the effects of dehydration on children's skin
#44Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#45IN-VITRO METHOD FOR IDENTIFYING AND ANALYSING ION CHANNELS AND/OR WATER CHANNELS AND/OR RECEPTORS OF SIGNAL TRANSDUCTION USING A THREE-DIMENSIONAL CELL CULTURE MODEL OF THE SWEAT GLAND
#46BIOMOLECULE EXTRACTION METHOD, EXTRACTION SYSTEM, AND EXTRACTION CONTAINER
#47ACTIVATION OF TRPV4 ION CHANNEL BY PHYSICAL STIMULI AND CRITICAL ROLE FOR TRPV4 IN ORGAN-SPECIFIC INFLAMMATION AND ITCH
#48ANTIBODY SPECIFIC TO PROFILAGGRIN C-TERMINAL DOMAIN, AND USE THEREOF
#49METHODS OF TREATING DISEASES WHICH ARE MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE CELLS
#50BIOMARKERS FOR DIAGNOSING KELOID SKIN OR KELOID SCAR, AND USE THEREOF
#51Methods and Systems for Improving Skin Condition
#52Methods of using antibodies to determine periostin levels in a sample
#53Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator
#54Activators of TonEBP for use for hydrating skin
#55METHODS OF VALIDATING CANDIDATE COMPOUNDS FOR USE IN TREATING COPD AND OTHER DISEASES
#56Method for Evaluating the Harmful Effects of Urine on Children's Skin
#57Method for screening for sunlight protection functional material and method for evaluating sunlight protection effect
#58Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population
#59ACTIVATION OF TRPV4 ION CHANNEL BY PHYSICAL STIMULI AND CRITICAL ROLE FOR TRPV4 IN ORGAN-SPECIFIC INFLAMMATION AND ITCH
#60Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#61Method of identifying cosmetic agents for moisturizing skin
#62TRPA1 and TRPV4 inhibitors and methods of using the same for organ-specific inflammation and itch
#63Method for evaluating the harmful effects of urine on children's skin
#64Method for evaluating condition of skin dryness
#65Systems and methods for analyzing persistent homeostatic perturbations
#66METHODS FOR IMPROVING SKIN QUALITY
#67Methods for measurement of inhibition of c-Jun N-terminal kinase in skin
#68DIFFERENTIAL DIAGNOSIS OF ECZEMA AND PSORIASIS
#69Predictive method of characterizing the radiosensitivity and tissular reaction of a patient to therapeutic ionizing radiation
#70Predictive method for determining tissual radiosensitivity
#71COSMETIC USE OF DERMICIDIN, OR ANALOGUES OR FRAGMENTS THEREOF, FOR THE PREVENTION AND/OR TREATMENT AND DIAGNOSIS OF OILY SKIN AND AESTHETIC SKIN DISORDERS ASSOCIATED THEREWITH
#72In vitro method for screening for candidate compounds for preventing and/or attenuating ageing of the skin, and/or for hydrating the skin
#73Method for evaluating the harmful effects of UV on children's skin
#74Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#75Corneodesomosomes and barrier function maturation
#76Activation of TRPV4 ion channel by physical stimuli and critical role for TRPV4 in organ-specific inflammation and itch
#77Methods for measurement of inhibition of c-Jun N-terminal kinase in skin
#78Lateral flow assay device
#79Use of biomarkers for evaluating the effectiveness of active ingredients
#80Methods and products for in vitro diagnosis, in vitro prognosis and the development of drugs against invasive carcinomas
#81Cell culture models for validating candidate compounds for use in treating COPD and other diseases
#82Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator
#83METHOD FOR IDENTIFYING MOLECULAR MARKERS OF CHILDREN'S SKIN
#84Method for determining age independently of sex
#85Activation of TRPV4 ion channel by physical stimuli and critical role for TRPV4 in organ-specific inflammation and itch
#86TREATING DISEASES BY MODULATING A SPECIFIC ISOFORM OF MKL1
#87Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicator
#88Use of complex forms of calmodulin-like skin protein CLSP
#89Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#90Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#91BIOMARKERS FOR PSORIASIS
#92Molecular flux rates through critical pathways measured by stable isotope labeling In Vivo, as biomarkers of drug action and disease activity
#93Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#94In vitro method using human skin for evaluating the influence of ABC transporters
#95Process for treating an individual with an esthetic defect of skin by modulating SASPase FLG2 complex
#96Peptides that modulate complex SASPase-FLG2
#97COSMETIC USE OF DERMICIDIN, AND ANALOGUES OR FRAGMENTS THEREOF
#98BIOMARKERS FOR PSORIASIS
#99Methods of validating candidate compounds for use in treating COPD and other diseases
#100METHODS AND KITS FOR DETECTING MELANOMA
#101Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells
#102PROGNOSTIC TESTS FOR DEVELOPMENT OF DERMAL STRETCH MARKS AND IMPLICATIONS FOR THE PREVENTATIVE TREATMENT THEREOF
#103Method for screening ameliorants of dry skin caused by atopic dermatitis using bleomycin hydrolase activity as indicator
#104Procollagen C-proteinase enhancer (PCPE) biomarker for bone formation
#105Cosmetic use of lacritin-type polypeptides
#106Biomarker-based methods for identifying and formulating compositions that improve skin quality and reduce the visible signs of aging in skin
#107Polypeptides for the in vitro assessment of the sensitising potential of a test compound
#108POTENCY MARKERS
#109Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#110GENETIC POLYMORPHISMS ASSOCIATED WITH PSORIASIS, METHODS OF DETECTION AND USES THEREOF
#111Tape stripping methods for analysis of skin desease and pathological skin state
#112MODULATORS OF MONOGLYCERIDE LIPASE IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#113Biomarker-based methods for formulating compositions that improve skin quality and reduce the visible signs of aging in skin for individuals in a selected population
#114Biomarker-Based Methods For Formulating Compositions That Improve Skin Quality And Reduce The Visible Signs Of Aging In Skin
#115Methods For Improving Skin Quality
#116Methods For Improving Skin Quality
#117Methods For Improving Skin Quality
#118Methods For Improving Skin Quality
#119Methods For Improving Skin Quality
#120Method for diagnosing and creating immunogenic tolerance in contact allergy and other epithelial immunotoxicological ailments
#121PACAP SIGNALING PATHWAY MODULATORS FOR TREATING INFLAMMATORY SKIN DISEASES HAVING A NEUROGENIC COMPONENT, NOTABLY ROSACEA, AND COMPOSITIONS COMPRISED THEREOF
#122ADFP MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA
#123Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
#124NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF PSORIASIS
#125Monitoring skin metabolism products for evaluating burn injury
#126Method for Assessing the Damage of Keratin Fibers
#127Noninvasive method for measuring histamine from skin as an objective measurement of itch
#128COSMETIC USE OF PLAKOGLOBIN-TYPE PROTEINS
#129Metabonomic Methods to Assess Health of Skin
#130Cosmetic use of a protein belonging to the ribonuclease family
#131BIOMARKERS FOR TRICHOGENICITY
#132Use of complex forms of calmodulin-like skin protein CLSP
#133PROGNOSTIC TESTS FOR DEVELOPMENT OF DERMAL STRETCH MARKS AND IMPLICATIONS FOR THE PREVENTATIVE TREATMENT THEREOF
#134Methods of using IL-31 antagonists in diseases mediated by cutaneous lymphocyte antigen positive T cells
#135NON-INVASIVE METHOD FOR COLLECTING BIOLOGICAL DATA FOR ESTABLISHING A DIAGNOSIS OF A CUTANEOUS PATHOLOGY
#136Use of soluble forms of the Desmoglein I protein for the purposes of screening for anti-ageing active agents
#137Method for assaying the antioxidant capacity of a skin care product
#138Determining Age Ranges of Skin Samples
#139METHOD OF EVALUATING ANTIWRINKLE SUBSTANCE AND METHOD OF ASSESSING THE SKIN
#140Filaggrin
#141Skin aging marker and technique for use thereof
#142METHODS OF TREATING DISEASES WHICH ARE MEDIATED BY CUTANEOUS LYMPHOCYTE ANTIGEN POSITIVE CELLS
#143Method for determining atopic dermatitis using protein marker
#144Novel compositions and method for the treatment of psoriasis
#145Method for evaluating skin condition using squamous cell carcinoma antigen as marker
#146Method Of Evaluating Degree Of Skin Sensitivity Using Squamous Cell Carcinoma Antigen As An Indicator Thereof
#147Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#148Methods of predicting therapeutic response in atopic dermatitis to IL-31 antagonists
#149ACNE LESION BIOMARKERS AND MODULATORS THEREOF
#150DIAGNOSIS AND TREATMENT OF DISEASE
#151Personalized skin care composition and method for production thereof
#152Novel Genes involved in Epidermal differentiation, and uses thereof
#153Method for the determination of the composition of textile fibers
#154Use of Slurp-1 for treating diseases related to acetylcholine receptor dysfunction
#155Metabonomic methods to assess health of skin
#156Tape stripping methods for analysis of skin disease and pathological skin state
#157Methods for determining the relative benefits and/or evaluating quantitative changes of products on epithelial tissue
#158Methods for determining the relative benefits and/or evaluating quantitative changes of products on epithelial tissue
#159Methods for determining the relative benefits and/or evaluating quantitative changes of products on epithelial tissue
#160Methods for determining the relative benefits and/or evaluating quantitative changes of products on epithelial tissue
#161Hepoxilins and modulators of ichthyin for treatment skin disorders
#162Method for determining the degree of protein oxidation in a skin sample using oxidized protein in stratum corneum as an indicator
#163Triple polypeptide complexes
#164Time-resolved non-invasive optometric device for medical diagnostic
#165Methods and compositions for inhibiting angiogenesis
#166Characterization of microbial deposition and immune response at the basement membrane and methods relating thereto
#167Nouvelles compositions et methods de traitement du psoriasis
#168Inflammatory skin disease-related slurp-2 gene and utilization thereof
#169Method for evaluating oxidized protein in horny cell layer
#170Methods and compositions that affect melanogenesis
#171Methods of predicting therpeutic response in atopic dermatitis to IL-31 antagonists
#172Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
#173Method of saying alastin digestion product and assay kit, method of detecting aortic dissection and detection kit
#174Prognostic tests for development of dermal stretch marks and implications for the preventive treatment thereof
#175Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#176Tape stripping methods for analysis of skin disease and pathological skin state
#177Process for production of a regioselective membrane
#178Methods for determining the relative benefits and/or evaluating quantitative changes of products on epithelial tissue
#179Drugs for ameliorating itch, rough skin or hypersensitive skin or for whitening via inhibition of the production and release of stem cell factor
#180Personalized cosmetics
#181Diagnostic for scleroderma
#182Oligopeptides for promoting hair growth
#183Use of SLURP-1 compositions for treating schizophrenia
#184Generating skin care recommendations for a user based on skin product attributes and user location and demographic data
#185Human ex vivo skin model and its use in methods of identifying modulators of skin inflammation